ARHGEF3 Deletion Increase Bone Formation and Suppresses Bone Resorption in Adult Mice
Clicks: 1
ID: 316982
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #114 of 119 articles by views in journal of bone and mineral research : the official journal of the american society for bone and mineral research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
ARHGEF3 (also known as XPLN) is a Rho guanine nucleotide exchange factor that activates RhoA/B. Variants in the ARHGEF3 gene are associated with hip and spine BMD and fracture risk, suggesting ARHGEF3 may play key role in maintaining bone mass. However, the extent to which ARHGEF3 facilitates the anabolic and catabolic effects of RhoA are unclear alongside the down-stream impact on bone mass. We report using knockout mice that ARHGEF3 deletion leads to significant gains in cortical area and moment of inertia, driven by increased periosteal bone formation. Increased periosteal bone formation was attributed to osteocytes' down-regulation of sclerostin and Dkk1 combined with increased Wnt3a and Wnt5a expression. In contrast, endocortical bone formation was reduced in KO mice and attributed to deficits in mineralization despite gains in osteoblast viability and alkaline phosphatase activity. ARHGEF3 deletion also suppressed bone resorption despite no direct effect on osteoclastogenesis. Instead, the decrease in osteoclast numbers and bone resorption in the absence of ARHGEF3 is attributed to decreased M-CSF levels among osteoblasts and osteoblast precursors. Collectively, our findings demonstrate that ARHGEF3 deletion has pro-anabolic and anti-catabolic effects that increase bone mass and may offer a novel target for preventing bone loss in an aging population.
| Reference Key |
openalex_W7164371109
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Amit Chougule, Chunbin Zhang, Jordan Denbow, Nickolas Vinokurov, Joseph D. Gardinier |
| Journal | journal of bone and mineral research : the official journal of the american society for bone and mineral research |
| Year | 2026 |
| DOI |
10.1093/jbmr/zjag099
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.